According to this meta-analysis, psoriatic arthritis (PsA) affects 112 out of every 100,000 adults globally, with higher rates observed in Europe and North America than in Asia and South America ...

Psoriatic arthritis treatment has improved and remission is possible. But not everyone gets the care they need. Find out what you can do to improve your health and feel better.

When I was diagnosed with psoriatic arthritis 2 years ago at the age of 24, I almost wept with relief. For years, I’d experienced puzzling symptoms. Dark purple-brown flakes on the back of my ...

Patients with psoriatic arthritis (PsA) have a higher prevalence of diabetes mellitus (DM) compared to the general population ...

Psoriatic arthritis is a chronic inflammatory condition that can cause limited mobility, pain, and illness. A person may apply for disability benefits if arthritis affects their ability to work ...

Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and ... with prevalence rates showing equal distribution between men and ...

Patients with psoriatic arthritis demonstrate a “substantial prevalence” of radiographic damage at baseline, which is related to time since diagnosis, according to data published in Arthritis ...

Common Comorbidities of Psoriatic Arthritis. Patients with psoriatic arthritis demonstrated an increased prevalence of cardiovascular disease (CVD), obesity and metabolic syndrome, and liver ...

The market for Psoriatic Arthritis Treatment was valued at US$ 7.95 billion in 2021 and is anticipated to grow at a CAGR of 7.5% through 2032.. Psoriasis is a chronic inflammatory skin condition ...

A considerable number of people in India suffer from psoriatic arthritis, with prevalence rates ranging from 0.5% to 2.5% among the population. However, despite its prevalence, ...

Krajewska-Włodarczyk M, Owczarczyk-Saczonek A, Placek W. Prevalence and severity of fatigue in psoriasis and psoriatic arthritis. Postepy Dermatol Alergol . 2020;37(1):46-51. doi:10.5114/ada.2019 ...